| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABSTRACTS 23rd Congress of the European Society for MedicalOncology. November 610, 1998 Athens Greece
|
|
|
1998
|
9 |
4 |
p. 1-174
174 p.
|
artikel
|
| 2 |
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|
González, G.
|
|
|
9 |
4 |
p. 431-435
|
artikel
|
| 3 |
A novel cancer vaccine composed of human-recombinant epidermal growthfactor linked to a carrier protein: Report of a pilot clinical trial
|
G. González
|
|
1998
|
9 |
4 |
p. 431-435
5 p.
|
artikel
|
| 4 |
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer
|
Castellano, D.
|
|
|
9 |
4 |
p. 457-459
|
artikel
|
| 5 |
A phase II study of a novel gemcitabine plus cisplatin regimenadministered every three weeks for advanced non-small-cell lung cancer
|
D. Castellano
|
|
1998
|
9 |
4 |
p. 457-459
3 p.
|
artikel
|
| 6 |
Awards, appointments
|
|
|
|
9 |
4 |
p. 347-348
|
artikel
|
| 7 |
Book review
|
Iggo, R.
|
|
|
9 |
4 |
p. 462
|
artikel
|
| 8 |
Book review
|
Cervera, E.
|
|
|
9 |
4 |
p. 350
|
artikel
|
| 9 |
Carboplatin toxic effects on the peripheral nervous system of therat
|
G. Cavaletti
|
|
1998
|
9 |
4 |
p. 443-447
5 p.
|
artikel
|
| 10 |
Carboplatin toxic effects on the peripheral nervous system of the rat
|
Cavaletti, G.
|
|
|
9 |
4 |
p. 443-447
|
artikel
|
| 11 |
Clinical course of breast cancer patients with metastases confined to thelungs treated with chemotherapy
|
E. A. Diaz-Canton
|
|
1998
|
9 |
4 |
p. 413-418
6 p.
|
artikel
|
| 12 |
Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy* * Presented at the 32nd American Society of Clinical Oncology Meeting, Philadelphia, PA, 20 May 1996.
|
Diaz-Canton, E.A.
|
|
|
9 |
4 |
p. 413-418
|
artikel
|
| 13 |
Clinical evaluation of whole-body ^18F-fluorodeoxyglucosepositron emission tomography in the detection of liver metastases
|
R. Hustinx
|
|
1998
|
9 |
4 |
p. 397-401
5 p.
|
artikel
|
| 14 |
Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases* * This work was presented in part at the 1996 European Association of Nuclear Medicine Congress in Copenhagen.
|
Hustinx, R.
|
|
|
9 |
4 |
p. 397-401
|
artikel
|
| 15 |
Contents of the next issue
|
|
|
|
9 |
4 |
p. v
|
artikel
|
| 16 |
Copyright
|
|
|
|
9 |
4 |
p. iii
|
artikel
|
| 17 |
Cost-effectiveness of interferon-α for chronic myeloid leukemia
|
Goldman, J.M.
|
|
|
9 |
4 |
p. 351-352
|
artikel
|
| 18 |
Cost-effectiveness of interferon- for chronic myeloidleukemia
|
J. M. Goldman
|
|
1998
|
9 |
4 |
p. 351-352
2 p.
|
artikel
|
| 19 |
Cost-effectiveness of interferon in chronic myeloid leukaemia: Analysis of four clinical studies
|
Messori, A.
|
|
|
9 |
4 |
p. 389-396
|
artikel
|
| 20 |
Cost-effectiveness of interferon in chronic myeloid leukaemia: Analysisof four clinical studies
|
A. Messori
|
|
1998
|
9 |
4 |
p. 389-396
8 p.
|
artikel
|
| 21 |
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients
|
Bergh, J.
|
|
|
9 |
4 |
p. 403-411
|
artikel
|
| 22 |
Dosage of adjuvant G-CSF (filgrastim)-supported FECpolychemotherapy based on equivalent haematological toxicity in high-riskbreast cancer patients
|
J. Bergh
|
|
1998
|
9 |
4 |
p. 403-411
9 p.
|
artikel
|
| 23 |
Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients
|
Grilli, R.
|
|
|
9 |
4 |
p. 365-374
|
artikel
|
| 24 |
Drug addiction: Change of attitude in the US?
|
|
|
|
9 |
4 |
p. 347
|
artikel
|
| 25 |
Editorial Board
|
|
|
|
9 |
4 |
p. iv
|
artikel
|
| 26 |
European center for special radiotherapy
|
|
|
|
9 |
4 |
p. 345-346
|
artikel
|
| 27 |
Germany and Switzerland lukewarm on anti-smoking
|
|
|
|
9 |
4 |
p. 347
|
artikel
|
| 28 |
Hematopoietic lineages in health and disease. N. G. Testa, B. I. Lord,T. M. Dexter (eds). Marcel Dekker inc., New York/Basel/Hong Kong, 1997. 384pp, ill. 150.00.
|
E. Cervera
|
|
1998
|
9 |
4 |
p. 350-350
1 p.
|
artikel
|
| 29 |
In this issue
|
|
|
|
9 |
4 |
p. v
|
artikel
|
| 30 |
Irinotecan-induced immune thrombocytopenia
|
Bozec, L.
|
|
|
9 |
4 |
p. 453-455
|
artikel
|
| 31 |
Irinotecan-induced immune thrombocytopenia
|
L. Bozec
|
|
1998
|
9 |
4 |
p. 453-455
3 p.
|
artikel
|
| 32 |
Malignant effusions contain lysophosphatidic acid (LPA)-like activity
|
Westermann, A.M.
|
|
|
9 |
4 |
p. 437-442
|
artikel
|
| 33 |
Malignant effusions contain lysophosphatidic acid (LPA)-likeactivity
|
A. M. Westermann
|
|
1998
|
9 |
4 |
p. 437-442
6 p.
|
artikel
|
| 34 |
More on dose-intensity of anthracyclines in breast cancer
|
Venturini, M.
|
|
|
9 |
4 |
p. 461
|
artikel
|
| 35 |
More on dose-intensity of anthracyclines in breast cancer
|
M. Venturini
|
|
1998
|
9 |
4 |
p. 461-461
1 p.
|
artikel
|
| 36 |
Ovarian cancer cisplatin-resistant cell lines: Multiple changes including collateral sensitivity to Taxol
|
Perego, P.
|
|
|
9 |
4 |
p. 423-430
|
artikel
|
| 37 |
Perhaps not everyone knows that…
|
|
|
|
9 |
4 |
p. 348-349
|
artikel
|
| 38 |
PET scanning in clinical oncology
|
Timothy, A.R.
|
|
|
9 |
4 |
p. 353-355
|
artikel
|
| 39 |
PET scanning in clinical oncology
|
A. R. Timothy
|
|
1998
|
9 |
4 |
p. 353-355
3 p.
|
artikel
|
| 40 |
Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests
|
Parchment, R.E.
|
|
|
9 |
4 |
p. 357-364
|
artikel
|
| 41 |
Predicting hematological toxicity (myelosuppression) of cytotoxic drugtherapy from in vitro tests
|
R. E. Parchment
|
|
1998
|
9 |
4 |
p. 357-364
8 p.
|
artikel
|
| 42 |
Prof. Dr. E. van der Schueren
|
Hossfeld, D.K.
|
|
|
9 |
4 |
p. 343
|
artikel
|
| 43 |
Prof. Dr. E. van der Schueren
|
D. K. Hossfeld
|
|
1998
|
9 |
4 |
p. 343-343
1 p.
|
artikel
|
| 44 |
Prognostic and predictive value of p53. J. G. M. Klijn (ed). ESO.Elsevier Press, Amsterdam/Lausanne/New York/Oxford/Shannon/Singapore/Tokyo,1997. 174 pp, 95.00, Dfl 160.00.
|
Richard Iggo
|
|
1998
|
9 |
4 |
p. 462-462
1 p.
|
artikel
|
| 45 |
Psoriasiform lesions as paraneoplastic manifestation in Hodgkin’s disease
|
Milionis, H.J.
|
|
|
9 |
4 |
p. 449-452
|
artikel
|
| 46 |
Psoriasiform lesions as paraneoplastic manifestation in Hodgkinsdisease
|
H. J. Milionis
|
|
1998
|
9 |
4 |
p. 449-452
4 p.
|
artikel
|
| 47 |
Reply to the letter More on dose-intensity of anthracyclines in breastcancer
|
M. Piccart
|
|
1998
|
9 |
4 |
p. 461-461
1 p.
|
artikel
|
| 48 |
Reviews on evidence-based cancer medicine
|
Williams, C.J.H.
|
|
|
9 |
4 |
p. 375
|
artikel
|
| 49 |
Reviews on evidence-based cancer medicine
|
C. J. H. Williams
|
|
1998
|
9 |
4 |
p. 375-375
1 p.
|
artikel
|
| 50 |
Searching the medical literature for the best evidence to solve clinical questions
|
Hunt, D.L.
|
|
|
9 |
4 |
p. 377-383
|
artikel
|
| 51 |
Searching the medical literature for the best evidence to solve clinicalquestions
|
D. L. Hunt
|
|
1998
|
9 |
4 |
p. 377-383
7 p.
|
artikel
|
| 52 |
Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin’s lymphoma
|
Clark, F.L.
|
|
|
9 |
4 |
p. 385-387
|
artikel
|
| 53 |
Successful treatment with lamivudine for fulminant reactivated hepatitisB infection following intensive therapy for high-grade non-Hodgkinslymphoma
|
F. L. Clark
|
|
1998
|
9 |
4 |
p. 385-387
3 p.
|
artikel
|
| 54 |
Survival of patients with visceral metastatic melanoma from an occult primary lesion: A retrospective matched cohort study
|
Vijuk, G.
|
|
|
9 |
4 |
p. 419-422
|
artikel
|
| 55 |
Survival of patients with visceral metastatic melanoma from an occultprimary lesion: A retrospective matched cohort study
|
G. Vijuk
|
|
1998
|
9 |
4 |
p. 419-422
4 p.
|
artikel
|
| 56 |
Table of Contents
|
|
|
|
9 |
4 |
p. ii-iii
|
artikel
|
| 57 |
This letter was referred to the author, who responds as follows:
|
Piccart, M.
|
|
|
9 |
4 |
p. 461
|
artikel
|
| 58 |
Will the nomination of Dr. Brundtland help cancer care in the world?
|
|
|
|
9 |
4 |
p. 345
|
artikel
|
| 59 |
Will the nomination of Dr. Brundtland help cancer care in the world?;European center for special radiotherapy; Xenotransplants: Moratorium or not?;Germany and Switzerland lukewarm on anti-smoking; Drug addiction: Change ofattitude in the US?; Awards, appointments; Perhaps not everyone knowsthat...
|
|
|
1998
|
9 |
4 |
p. 345-349
5 p.
|
artikel
|
| 60 |
Xenotransplants: Moratorium or not?
|
|
|
|
9 |
4 |
p. 346
|
artikel
|
Tijdschrift beschrijving